Limestone Investment Advisors LP
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 2075597
NEW YORK, NY
Position in DMII
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,519,060
+$1,400,417 QoQ
Shares Held
151,000
+1168.9% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#50
of 74 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMII Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Jun 30, 2026Limestone Investment Advisors LP holds $9,385,175 across 13 Shell Companies names. DMII ranks #1 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMII |
Drugs Made In America Acquisition II Corp.
This page
|
151,000 | $1,519,060 | |
| 2 | TRAD |
APEX Tech Acquisition Inc.
|
143,251 | $1,425,347 | |
| 3 | GIW |
GigCapital8 Corp.
|
101,000 | $1,016,969 | |
| 4 | RFAM |
RF Acquisition Corp III
|
100,000 | $990,000 | |
| 5 | XFLH |
XFLH Capital Corp
|
91,220 | $909,463 | |
| 6 | PONO |
Pono Capital Four, Inc.
|
84,679 | $843,402 | |
| 7 | CTAA |
Clearthink 1 Acquisition Corp.
|
75,627 | $749,463 | |
| 8 | LAFA |
LaFayette Acquisition Corp.
|
52,018 | $524,341 |
All Filings in DMII
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,519,060 | 151,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $118,643 | 11,900 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||